Press release
Renal Biomarkers Market: Unraveling the Potential, Poised to Reach US$ 2.6 Billion by 2032
Renal Biomarker Market
One of the key factors contributing to the market's expansion is the increasing burden of chronic kidney diseases (CKD) and acute kidney injury (AKI). CKD is a global health concern, affecting millions of people worldwide, and early detection of kidney dysfunction is crucial to prevent disease progression and improve patient outcomes. Renal biomarkers play a vital role in identifying kidney damage at an early stage, enabling timely intervention and appropriate treatment.
Unlock Early Detection with Renal Biomarker Tests. Request Your Sample Today :https://www.futuremarketinsights.com/reports/sample/rep-gb-1731
Global demand for renal biomarkers is expected to rise 7.0% year on year to US$ 2.6 billion by 2032, driven by:
•Global increases in kidney disease incidence
•a sizable geriatric population, particularly in developing countries
•The prevalence of multiple co-morbidities is increasing.
•Diabetes, obesity, and hypertension are all becoming more common.
•an increase in the world's vulnerable ageing population
Moreover, the aging population and the rise in risk factors such as diabetes, hypertension, and obesity have contributed to the growing prevalence of kidney disorders. As the elderly population increases, the demand for renal biomarkers for timely diagnosis and management of kidney diseases is expected to rise.
The market offers a variety of renal biomarker tests, including serum creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (UACR), among others. These biomarkers help healthcare professionals assess kidney function, identify the presence of proteinuria (a marker of kidney damage), and monitor disease progression.
Competitive Landscape
Key market players within the renal biomarker market are concentrating on new product launches and approvals, investments in research and development, partnerships, acquisitions, and collaborations to gain a competitive edge in the market.
Key instances of development within the market include:
•SphingoTec GmbH reported the publication of unique study findings including their patented pencil kidney function biomarker in BMC Emergency Medicine in December 2019.
•In order to include novel kidney disease biomarkers found by the center's researchers in Renalytix AI's KidneyIntelX platform, the business expanded its collaboration with the Joslin Diabetes Center in April 2021.
Key Companies Profiled :
•Abbott Laboratories
•BioPorto Diagnostics AS
•F. Hoffmann-La Roche AG
•Thermo Fisher Scientific Inc.
•Nexelis (Pacific Biomarkers)
•BioMérieux
•Sphingotec GmbH
•Randox Laboratories Ltd
•Siemens Healthineers AG
•Beckman Coulter Inc. (Danaher Corporation)
•Bio-Rad Laboratories Inc.
•Enzo Biochem Inc.
•PerkinElmer Inc.
•Renalytix AI
Discover the power of methodology-driven insights today:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1731
Key Market Segments Covered in Renal Biomarker Industry Research
By Biomarker:
•Functional Biomarker
oSerum Creatinine
oSerum Cystatin C
oUrine Albumin
•Up-Regulated Proteins
oNeutrophil Gelatinase-Associated Lipocalin
oKidney Injury Molecule-1
oInterleukin-18
•Others
By Diagnostic Technique:
•Enzyme Linked Immunosorbent Assay (ELISA)
•Particle-Enhanced Turbidimetric Immunoassay (PETIA)
•Colorimetric Assay
•Chemiluminescent Enzyme Immunoassay (CLIA)
•Liquid Chromatography-Mass Spectrometry (LS-MS)
By End User:
•Diagnostic Labs
•Outpatient Clinics
•Research Centers
•Hospitals
By Region:
•North America
•Latin America
•Europe
•South Asia
•East Asia
•Oceania
•Middle East and Africa (MEA)
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
APOL1 Mediated Kidney Disease Market:
https://www.futuremarketinsights.com/reports/apol-1-mediated-kidney-disease-market
Late Stage Chronic Kidney Disease Therapeutics Market:
https://www.futuremarketinsights.com/reports/late-stage-chronic-kidney-disease-therapeutics-market
Autosomal Dominant Polycystic Kidney Disease Treatment Market: https://www.futuremarketinsights.com/reports/autosomal-dominant-polycystic-kidney-disease-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/renal-biomarker-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Renal Biomarkers Market: Unraveling the Potential, Poised to Reach US$ 2.6 Billion by 2032 here
News-ID: 3202532 • Views: …
More Releases from Future market Insights
Aerospace Fluid Conveyance System Market to Reach USD 4.3 Billion by 2035 with I …
The global Aerospace Fluid Conveyance System Market is witnessing steady growth, driven by the increasing demand for advanced fluid handling solutions across commercial and military aircraft. Valued at USD 3.1 billion in 2025, the market is projected to reach USD 4.3 billion by 2035, registering a healthy CAGR of 3.4%. Both established and emerging manufacturers are actively innovating to meet the evolving needs of the aviation sector.
Market Dynamics and Growth…
Automotive Starter and Alternator Market to Reach USD 45.4 Billion by 2035 Amid …
The global Automotive Starter and Alternator Market is on track for substantial expansion, driven by rapid advancements in vehicle technology and the growing focus on electrification. Valued at USD 29.3 billion in 2025, the market is projected to reach USD 45.4 billion by 2035, registering a CAGR of 4.5% during the forecast period. The growth reflects the automotive industry's continuous evolution toward fuel-efficient and sustainable systems that integrate reliability, performance,…
Connected Aircraft Market Soars to USD 63.6 Billion by 2035, Driven by Connectiv …
The global Connected Aircraft Market is poised for transformative growth, projected to rise from USD 6.8 billion in 2025 to USD 63.6 billion by 2035, registering an impressive CAGR of 25.1% over the forecast period. This surge is being fueled by airlines' growing focus on enhancing operational efficiency, passenger experience, and safety through advanced connectivity solutions.
Industry leaders such as Honeywell International Inc., Thales Group, Raytheon Technologies Corporation, BAE Systems PLC,…
Slingshot/3-Wheeled Motorcycle Market Set to Hit USD 1.8 Billion by 2035 Driven …
The global Slingshot/3-Wheeled Motorcycle Market is on track to witness sustained growth, driven by shifting consumer lifestyles, urban mobility trends, and a rising interest in alternative transportation. Valued at USD 1.3 billion in 2025, the market is projected to reach USD 1.8 billion by 2035, expanding at a CAGR of 2.9%.
During the early growth phase (2021-2025), the market experiences gradual expansion, fueled by consumers' growing appetite for distinctive vehicles that…
More Releases for Renal
Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market?
The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors…
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032.
Renal Osteodystrophy Market Overview
The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early…
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development…
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market?
The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in…
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period…
